Removable Complete Airway Repositioning and/or Expansion oral appliances are indicated for adults with severe obstructive sleep apnea.

Orne discusses the forces impacting the life sciences market and how companies are reacting.

Roche's Elecsys HBeAg quant is an immunoassay able to determine the presence and quantity of the hepatitis B e antigen in human serum and plasma.

PD-L1 IHC 22C3 pharmD approved to help identify patients who may be eligible to receive treatment with pembrolizumab (Keytruda) to treat gastric or gastroesophageal junction adenocarcinoma.

The Elecsys NfL test is designed to aid in detecting disease activity and to offer insights in disease management for patients with multiple sclerosis.

The newly approved Alinity m high risk human papillomavirus (HPV) assay is indicated to detect HPV and for use in routine cervical cancer screening per professional medical guidelines.

The continued development of more convenient VR technology has improved usability, accessibility, and affordability across healthcare settings.

Ito discusses how data-driven AI can be utilized by the pharma industry.

Data asset expected to drive improvements in patient outcomes and care quality.

The system was used by doctors at the Cleveland Clinic.

Amy West, Head of US Digital Health & Innovation Strategy at Novo Nordisk, shares her insights on fostering collaboration, embracing change, and her compelling vision to revolutionize digital transformation and innovation in the field of healthcare.

How pharma companies can reduce the risk of failure with AI-based innovations.

The EluNIR-PERL drug-eluting stent is used for the treatment of coronary artery disease.

Joint venture combines GE’s background in ultrasound technology with Novo Nordisk’s experience with metabolic diseases.

Industry experts discuss the relationship between digital and traditional (key) opinion leaders and how companies are adjusting their strategies to harness the unique brand engagement benefits each role can provide in driving better patient outcomes.

Device adds new integration.

Device indicated for newly diagnosed glioblastoma.

New executive expected to lead market launch of new brain neuromodulation technology.

EnsoETM is designed to reduce the likelihood of ablation-related esophageal injury resulting from radiofrequency cardiac ablation procedures.

Sapio chemistry solution unifies small-molecule and large-molecule discovery workflows on a single platform.

Klein discusses how recent FDA draft guidelines will impact the use of SaMD in the life sciences industry.

Kalinovich previously worked at Wabtec as a corporate vice president.

How to cultivate trust & connections in life sciences in a time of AI bias.

Papa previously served as chairman and CEO of Bausch Health Companies.

In this Q&A with Pharmaceutical Executive®, Andrew Hopkins, founder and CEO of Exscientia, reveals how artificial intelligence (AI) is currently being utilized in the pharma industry, predictions for where AI can be implemented in the future, and what pharma fears most about AI.

The injector is designed for at-home or in-clinic use.

Copp comes to the company from McKinsey & Co.

Kirsch discusses the complexity of the drugs and the verification process, along with EVERSANA’s new platform, ACTICS eAccess.

THINK Surgical developed the system for total knee replacements.